Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)

This study has been completed.
Sponsor:
Collaborators:
Phytopharm
Covance
Information provided by:
Unilever R&D
ClinicalTrials.gov Identifier:
NCT01306422
First received: February 25, 2011
Last updated: February 28, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
No publications provided by Unilever R&D

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):